Technical Trend Overview and Price Movement
As of 20 Mar 2026, Hester Biosciences closed at ₹1,428.00, up from the previous close of ₹1,404.95. The stock’s 52-week range remains wide, with a high of ₹2,347.70 and a low of ₹1,246.75, indicating significant volatility over the past year. The recent price action suggests a tentative recovery attempt, yet the overall technical trend remains mildly bearish, a notable improvement from the prior strong sell rating.
The daily moving averages continue to signal bearishness, reflecting that short-term momentum is still under pressure. However, weekly indicators such as the MACD and KST have turned mildly bullish, hinting at a potential bottoming out or consolidation phase. Conversely, monthly MACD and Bollinger Bands remain bearish, underscoring persistent longer-term headwinds.
MACD and Momentum Oscillators: Divergent Signals
The Moving Average Convergence Divergence (MACD) indicator offers a nuanced view. On a weekly basis, the MACD is mildly bullish, suggesting that momentum could be building for a possible upward move in the near term. This is supported by the KST (Know Sure Thing) indicator, which also shows mild bullishness weekly. However, the monthly MACD remains bearish, indicating that the longer-term trend has yet to confirm a sustained recovery.
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This lack of momentum confirmation from RSI suggests that the stock is neither overbought nor oversold, reinforcing the idea of a consolidation phase rather than a decisive trend reversal.
Bollinger Bands and Moving Averages: Caution Prevails
Bollinger Bands, which measure volatility and potential price extremes, are mildly bearish on the weekly chart and bearish on the monthly chart. This implies that price volatility remains skewed towards downside risk in the medium term. The daily moving averages, which are more sensitive to recent price changes, continue to trend downward, signalling that short-term selling pressure has not yet abated.
On balance, these indicators suggest that while some technical momentum is building, investors should remain cautious as the stock has not yet broken decisively above key resistance levels or moving averages that would confirm a bullish trend.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
On-Balance Volume and Dow Theory: Mixed Market Sentiment
The On-Balance Volume (OBV) indicator, which tracks buying and selling pressure, is mildly bearish on the weekly timeframe and shows no clear trend monthly. This suggests that volume-driven momentum is weak, with sellers still exerting some influence. Dow Theory analysis reveals no clear trend on the weekly chart but indicates a mildly bullish trend monthly, reflecting some underlying optimism among longer-term investors.
These mixed signals highlight the stock’s current indecision phase, where neither buyers nor sellers have established clear dominance. This is consistent with the stock’s recent performance relative to the broader market.
Comparative Returns: Underperformance Against Sensex
Hester Biosciences’ returns over various periods reveal a pattern of underperformance relative to the Sensex benchmark. Over the past week, the stock declined by 0.93%, while the Sensex fell 2.40%, indicating a relative outperformance in the very short term. However, over one month and year-to-date periods, the stock has fallen 8.59% and 10.30% respectively, lagging behind the Sensex’s declines of 10.05% and 12.92%.
Longer-term returns paint a more challenging picture. Over three and five years, Hester Biosciences has declined by 16.74% and 19.99%, respectively, while the Sensex gained 27.97% and 48.84%. Even over a decade, despite a strong 221.19% gain for the stock, it only modestly outperformed the Sensex’s 197.39% rise. This performance disparity underscores the stock’s struggle to keep pace with broader market gains, reflecting sector-specific or company-specific challenges.
Mojo Score and Rating Update
MarketsMOJO assigns Hester Biosciences a Mojo Score of 42.0, categorising it as a Sell. This represents an upgrade from a previous Strong Sell rating dated 30 Jan 2026, signalling a slight improvement in the stock’s outlook. The micro-cap classification further emphasises the stock’s higher risk profile and limited market liquidity, factors that investors should weigh carefully.
The rating upgrade aligns with the observed technical shift from strongly bearish to mildly bearish, reflecting cautious optimism but not yet a full recovery in momentum or fundamentals.
Hester Biosciences Ltd or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investor Takeaway and Outlook
Hester Biosciences Ltd’s recent technical developments suggest a tentative shift in momentum, with weekly indicators hinting at mild bullishness while monthly signals remain cautious or bearish. The stock’s inability to decisively break above key moving averages and the mixed volume trends imply that investors should approach with prudence.
Given the stock’s micro-cap status and historical underperformance relative to the Sensex, it remains a higher-risk proposition within the Pharmaceuticals & Biotechnology sector. The upgrade from Strong Sell to Sell by MarketsMOJO reflects some improvement but stops short of a clear buy signal.
For investors considering exposure, monitoring the evolution of MACD and moving averages on weekly and monthly charts will be critical. A sustained break above resistance levels and confirmation from volume indicators could signal a more robust recovery. Until then, the stock’s technical profile suggests a cautious stance, favouring risk-managed positions or exploration of superior alternatives within the sector.
Summary of Key Technical Indicators:
- MACD: Weekly mildly bullish; Monthly bearish
- RSI: Neutral on weekly and monthly
- Bollinger Bands: Weekly mildly bearish; Monthly bearish
- Moving Averages: Daily bearish
- KST: Weekly mildly bullish; Monthly bearish
- Dow Theory: Weekly no trend; Monthly mildly bullish
- OBV: Weekly mildly bearish; Monthly no trend
Investors should continue to analyse these parameters in conjunction with fundamental developments and sector trends to make informed decisions.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
